T1	Participants 70 83	otospongiosis
T2	Participants 221 242	otospongiotic lesions
T3	Participants 358 424	One single tertiary care institution in a large, cosmopolitan city
T4	Participants 434 537	Twenty-six patients (n = 42 ears) with clinical, audiometric, and tomographic diagnosis of otosclerosis
T5	Participants 1264 1318	patients in the alendronate and sodium fluoride groups
T6	Participants 1421 1438	alendronate group
T7	Participants 1645 1670	activity of otospongiosis
